Side Effects of fluticasone and vilanterol oral inhalation: A Synthesis of Findings from 2 Studies

  1. Home
  2. Side Effects of fluticasone and vilanterol oral inhalation
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Side Effects of fluticasone and vilanterol oral inhalation: A Synthesis of Findings from 2 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of fluticasone and vilanterol oral inhalation: A Synthesis of Findings from 2 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Main Research Findings

Vilanterol (VI) is a long-acting beta2-agonist (LABA) that helps open up the airways, making breathing easier for people with asthma. 2 describes it as a once-daily medication, which is an improvement over other LABAs that need to be taken twice a day. Fluticasone furoate (FF) is an inhaled corticosteroid (ICS) that reduces inflammation in the airways, also helping with asthma control. 2 mentions this combination of VI and FF as a once-daily option for asthma treatment.

Another study, 1 , looked at the effects of different doses of ganciclovir, a drug used to treat cytomegalovirus (CMV) infections, especially in newborns. It found that the effectiveness and side effects of ganciclovir could vary depending on the dose given.

Reasons for Side Effects

Side effects happen when a medication interacts with the body in ways other than its intended effect. The side effects of fluticasone and vilanterol could be due to how each drug acts individually, or how they interact with each other. The study on ganciclovir 1 suggests that the amount of ganciclovir given could affect how much side effects occur and how severe they are.

Common Side Effects

Fluticasone and Vilanterol

The study on fluticasone and vilanterol 2 doesn't specifically mention side effects.

Ganciclovir

The study on ganciclovir 1 mentions that there are potential side effects associated with ganciclovir, but doesn't list specific ones.

Countermeasures for Side Effects

Fluticasone and Vilanterol

The study on fluticasone and vilanterol 2 doesn't discuss countermeasures for side effects.

Ganciclovir

The study on ganciclovir 1 doesn't provide information about countermeasures for side effects.

Comparison of Studies

Commonalities of Studies

Both studies are focused on evaluating the effectiveness and side effects of specific medications.

Differences in Studies

The study on fluticasone and vilanterol 2 focuses on its use for asthma management. The study on ganciclovir 1 looks at its effectiveness for treating cytomegalovirus infections in newborns. The study on fluticasone and vilanterol doesn't specifically discuss side effects.

Precautions for Application in Real Life

Fluticasone and vilanterol is a promising medication for people with asthma. However, more research is needed to understand its side effects. Always use it as directed by your doctor. Ganciclovir is used to treat CMV infections in newborns, but it's crucial to be aware of the potential side effects. Doctors will determine the right dose for each child based on their individual needs.

Limitations of Current Research

The study on fluticasone and vilanterol 2 doesn't provide enough information about side effects. The study on ganciclovir 1 lacks detailed information on the effectiveness and side effects in newborns with CMV infections.

Directions for Future Research

More research is needed to fully understand the side effects of fluticasone and vilanterol. Further studies comparing different doses of ganciclovir and their impact on newborns with CMV infections are also essential.

Conclusion

Fluticasone and vilanterol is a potentially valuable medication for asthma management, but more research is necessary to understand its side effects. Always follow your doctor's instructions for its use. Ganciclovir is used to treat CMV infections, but doctors need to carefully consider the potential side effects and determine the best dose for each patient.

Keywords
Benefit Keywords
CMV infection
1
Asthma control
2
Risk Keywords
Side effects
1
Literature analysis of 2 papers
Positive Content
2
Neutral Content
0
Negative Content
0
Article Type
1
0
0
1
2
1.

[Comparison of therapeutic effect of different doses of ganciclovir for neonatal congenital cytomegalovirus infection].

Author: HeXiao-Ri, ChenPing-Yang, WangTao, XieZong-De, HuJin-Tao, BoTao, GeJian-Fang

CMV infection
Side effects

This study compared the efficacy and side effects of relatively low and high doses of ganciclovir in the treatment of neonatal congenital cytomegalovirus (CMV) infection.

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
English AbstractA summary of a research paper/publication written in English for a wider audience.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : Chinese

2.

Vilanterol and fluticasone furoate for asthma.

Author: DwanKerry, MilanStephen J, BaxLynne, WaltersNicola, PowellColin

Asthma control

Vilanterol (VI) is a long-acting beta<sub>2</sub>-agonist (LABA) that can improve asthma symptoms, lung function, and reduce exacerbations. While other LABAs are twice-daily medications, VI is a once-daily therapy. Fluticasone furoate (FF) is an inhaled corticosteroid (ICS), and ICS therapy is recommended for asthma patients who need a "reliever" medication three or more times per week. Currently, only one once-daily ICS/LABA combination (FF/VI) is available.

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.